IDXX · CIK 0000874716 · operating
IDEXX LABORATORIES INC /DE (IDXX) is a in vitro & in vivo diagnostic substances company incorporated in DE, listed on the Nasdaq. With a market capitalization of $50.9 billion, IDEXX LABORATORIES INC /DE is a large-cap company. The stock currently trades at $638.58, up 0.29% today, with a 52-week range of $356.14–$769.98. The company trades at a trailing P/E of 48.7x and a forward P/E of 38.8x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $13.08 | $13.17 | +22.6% | |
| 2024 | $10.67 | $10.77 | +6.1% | |
| 2023 | $10.06 | $10.17 | +25.3% | |
| 2022 | $8.03 | $8.12 | -6.6% | |
| 2021 | $8.60 | $8.74 | +28.2% | |
| 2020 | $6.71 | $6.82 | +545.2% | |
| 2019 | $1.04 | $1.05 | +6.1% | |
| 2018 | $0.98 | $0.99 | +127.9% | |
| 2017 | $0.43 | $0.44 | -25.9% | |
| 2016 | $0.58 | $0.59 | +20.8% | |
| 2015 | $0.48 | $0.49 | -11.1% | |
| 2014 | $0.54 | $0.54 | -34.1% | |
| 2013 | $0.82 | $0.83 | +5.1% | |
| 2012 | $0.78 | $0.79 | +16.4% | |
| 2011 | $0.67 | $0.68 | -71.7% | |
| 2010 | $2.37 | $2.45 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-20 | 0000874716-26-000038 | SEC ↗ |
| 2024-12-31 | 2025-02-21 | 0000874716-25-000037 | SEC ↗ |
| 2023-12-31 | 2024-02-22 | 0000874716-24-000057 | SEC ↗ |
| 2022-12-31 | 2023-02-16 | 0000874716-23-000006 | SEC ↗ |
| 2021-12-31 | 2022-02-16 | 0000874716-22-000007 | SEC ↗ |
| 2020-12-31 | 2021-02-12 | 0000874716-21-000008 | SEC ↗ |
| 2019-12-31 | 2020-02-14 | 0000874716-20-000006 | SEC ↗ |
| 2018-12-31 | 2019-02-15 | 0000874716-19-000004 | SEC ↗ |
| 2017-12-31 | 2018-02-16 | 0000874716-18-000005 | SEC ↗ |
| 2016-12-31 | 2017-02-17 | 0000874716-17-000004 | SEC ↗ |
| 2015-12-31 | 2016-02-17 | 0000874716-16-000020 | SEC ↗ |
| 2014-12-31 | 2015-02-17 | 0000874716-15-000003 | SEC ↗ |